- Home
- SCWO vs INZY Comparison
SCWO vs INZY Comparison
Compare SCWO & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- INZY
- Stock Information
- Founded
- SCWO 2021
- INZY 2015
- Country
- SCWO United States
- INZY United States
- Employees
- SCWO 26
- INZY N/A
- Industry
- SCWO Environmental Services
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- INZY Health Care
- Exchange
- SCWO Nasdaq
- INZY Nasdaq
- Market Cap
- SCWO 64.3M
- INZY 188.2M
- IPO Year
- SCWO N/A
- INZY 2020
- Fundamental
- Price
- SCWO $0.41
- INZY $1.42
- Analyst Decision
- SCWO
- INZY Strong Buy
- Analyst Count
- SCWO 0
- INZY 8
- Target Price
- SCWO N/A
- INZY $17.75
- AVG Volume (30 Days)
- SCWO 405.6K
- INZY 1.0M
- Earning Date
- SCWO 03-28-2025
- INZY 03-11-2025
- Dividend Yield
- SCWO N/A
- INZY N/A
- EPS Growth
- SCWO N/A
- INZY N/A
- EPS
- SCWO N/A
- INZY N/A
- Revenue
- SCWO $313,930.00
- INZY N/A
- Revenue This Year
- SCWO N/A
- INZY N/A
- Revenue Next Year
- SCWO $5,180.00
- INZY N/A
- P/E Ratio
- SCWO N/A
- INZY N/A
- Revenue Growth
- SCWO N/A
- INZY N/A
- 52 Week Low
- SCWO $0.44
- INZY $1.24
- 52 Week High
- SCWO $1.99
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- SCWO 23.95
- INZY 31.52
- Support Level
- SCWO $0.54
- INZY $1.35
- Resistance Level
- SCWO $0.58
- INZY $1.45
- Average True Range (ATR)
- SCWO 0.06
- INZY 0.12
- MACD
- SCWO -0.00
- INZY 0.04
- Stochastic Oscillator
- SCWO 0.55
- INZY 43.42
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.